{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:23:55Z","timestamp":1793294635348,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","award":["0373100122119000013"],"award-info":[{"award-number":["0373100122119000013"]}],"id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Endolysin-based therapeutics are promising antibacterial agents and can successfully supplement the existing antibacterial drugs array. It is specifically important in the case of Gram-negative pathogens, e.g., ESKAPE group bacteria, which includes <jats:italic>Enterococcus faecium<\/jats:italic>, <jats:italic>Staphylococcus aureus<\/jats:italic>, <jats:italic>Klebsiella pneumoniae<\/jats:italic>, <jats:italic>Acinetobacter baumannii<\/jats:italic>, <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, and <jats:italic>Enterobacter<\/jats:italic> species, and are highly inclined to gain multiple antibiotic resistance. Despite numerous works devoted to the screening of new lytic enzymes and investigations of their biochemical properties, there are significant breaches in some aspects of their operating characteristics, including safety issues of endolysin use. Here, we provide a comprehensive study of the antimicrobial efficacy aspects of four Gram-negative bacteria-targeting endolysins LysAm24, LysAp22, LysECD7, and LysSi3, their <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> activity, and their biological safety. These endolysins possess a wide spectrum of action, are active against planktonic bacteria and bacterial biofilms, and are effective in wound and burn skin infection animal models. In terms of safety, these enzymes do not contribute to the development of short-term resistance, are not cytotoxic, and do not significantly affect the normal intestinal microflora <jats:italic>in vivo<\/jats:italic>. Our results provide a confident base for the development of effective and safe candidate dosage forms for the treatment of local and systemic infections caused by Gram-negative bacterial species.<\/jats:p>","DOI":"10.3389\/fmicb.2021.748718","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:23:19Z","timestamp":1634149399000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections"],"prefix":"10.3389","volume":"12","author":[{"given":"Daria V.","family":"Vasina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia P.","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Grigoriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria S.","family":"Yakimakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya M.","family":"Lendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Nikiforova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei A.","family":"Pochtovyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofey A.","family":"Remizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny V.","family":"Usachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia V.","family":"Shevlyagina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir G.","family":"Zhukhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail V.","family":"Fursov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy D.","family":"Potapov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei M.","family":"Vorobev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Aleshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei I.","family":"Laishevtsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine V.","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey M.","family":"Yudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem P.","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e01311","DOI":"10.1128\/AEM.01311-20","article-title":"Lysin LysMK34 of Acinetobacter baumannii bacteriophage PMK34 has a turgor pressure-dependent intrinsic antibacterial activity and reverts colistin resistance","volume":"86","author":"Abdelkader","year":"2020","journal-title":"Appl. Environ. Microbiol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antibiotics10020124","article-title":"Phage-encoded endolysins","volume":"10","author":"Abdelrahman","year":"2021","journal-title":"Antibiotics"},{"key":"ref3","author":"Antonova","year":"2021"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/v11030284","article-title":"Broad bactericidal activity of the myoviridae bacteriophage lysins LysAm24, LysECD7, and LysSi3 against gram-negative ESKAPE pathogens","volume":"11","author":"Antonova","year":"2019","journal-title":"Viruses"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/biom10030440","article-title":"Modulation of endolysin LysECD7 bactericidal activity by different peptide tag fusion","volume":"10","author":"Antonova","year":"2020","journal-title":"Biomol. Ther."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluating antimicrobial activity: A review","volume":"6","author":"Balouiri","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-induced changes in the intestinal microbiota and disease","volume":"22","author":"Becattini","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.1038\/s41598-020-64145-7","article-title":"In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens","volume":"10","author":"Blasco","year":"2020","journal-title":"Sci. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1128\/AAC.02668-14","article-title":"Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa","volume":"58","author":"Briers","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1021\/acsinfecdis.1c00222","article-title":"Membrane-permeable antibacterial enzyme against multidrug-resistant Acinetobacter baumannii","volume":"7","author":"Chen","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/v10050244","article-title":"An ointment consisting of the phage lysin LysGH15 and apigenin for decolonization of methicillin-resistant Staphylococcus aureus from skin wounds","volume":"10","author":"Cheng","year":"2018","journal-title":"Viruses"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1172\/JCI136577","article-title":"Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis","volume":"130","author":"Fowler","year":"2020","journal-title":"J. Clin. Invest."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/v12050545","article-title":"Antibiofilm activity of a broad-range recombinant endolysin LysECD7: in vitro and in vivo study","volume":"12","author":"Fursov","year":"2020","journal-title":"Viruses"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"126746","DOI":"10.1016\/j.micres.2021.126746","article-title":"Bacteriophage-encoded enzymes destroying bacterial cell membranes and walls, and their potential use as antimicrobial agents","volume":"248","author":"Grabowski","year":"2021","journal-title":"Microbiol. Res."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/1040841X.2020.1825333","article-title":"Resistance to peptidoglycan-degrading enzymes","volume":"46","author":"Grishin","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fmicb.2017.00293","article-title":"A novel antimicrobial endolysin, LysPA26, against Pseudomonas aeruginosa","volume":"8","author":"Guo","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.copbio.2020.08.014","article-title":"Lysins breaking down the walls of gram-negative bacteria, no longer a no-go","volume":"68","author":"Guti\u00e9rrez","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e02629","DOI":"10.1128\/AAC.02629-16","article-title":"Pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy volunteers","volume":"61","author":"Jun","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jgar.2020.01.005","article-title":"Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"22","author":"Kim","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/08927014.2021.1887151","article-title":"The novel endolysin XZ.700 effectively treats MRSA biofilms in two biofilm models without showing toxicity on human bone cells in vitro","volume":"37","author":"Kuiper","year":"2021","journal-title":"Biofouling"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1128\/AAC.04641-14","article-title":"Novel phage Lysin capable of killing the multidrug resistant gram-negative bacterium Acinetobacter Baumannii in a mouse bacteremia model","volume":"59","author":"Lood","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/v13040680","article-title":"The advantages and challenges of using endolysins in a clinical setting","volume":"13","author":"Murray","year":"2021","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/v10060292","article-title":"Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy","volume":"10","author":"Oliveira","year":"2018","journal-title":"Viruses"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.17.2.268-280.2004","article-title":"Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization","volume":"17","author":"Pfaller","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1086\/521305","article-title":"Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11","volume":"196","author":"Rashel","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e00024","DOI":"10.1128\/AAC.00024-19","article-title":"Isolation of phage lysins that effectively kill Pseudomonas aeruginosa in mouse models of lung and skin infection","volume":"63","author":"Raz","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ijantimicag.2017.08.027","article-title":"Inhibitory and bactericidal effect of Artilysin\u00ae Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates","volume":"51","author":"Schirmeier","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.copbio.2020.09.012","article-title":"Bacteriophage endolysins\u2014extending their application to tissues and the bloodstream","volume":"68","author":"Schmelcher","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","article-title":"Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci","volume":"115","author":"Stepanovi\u0107","year":"2007","journal-title":"APMIS"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","article-title":"The global preclinical antibacterial pipeline","volume":"18","author":"Theuretzbacher","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2019.06.004","article-title":"Non-traditional antibacterial therapeutic options and challenges","volume":"26","author":"Theuretzbacher","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000473872","article-title":"Successful treatment of chronic Staphylococcus aureus-related dermatoses with the topical endolysin staphefekt SA.100: a report of 3 cases","volume":"9","author":"Tott\u00e9","year":"2017","journal-title":"Case Rep. Dermatol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/antibiotics9020059","article-title":"Bacterial biofilm and its role in the pathogenesis of disease","volume":"9","author":"Vestby","year":"2020","journal-title":"Antibiotics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/v12020192","article-title":"TSPphg lysin from the extremophilic thermus bacteriophage TSP4 as a potential antimicrobial agent against both gram-negative and gram-positive pathogenic bacteria","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3389\/fmicb.2019.00887","article-title":"Core gut bacteria analysis of healthy mice","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.3389\/fmicb.2018.03302","article-title":"A novel phage PD-6A3, and its endolysin Ply6A3, with extended lytic activity against Acinetobacter baumannii","volume":"9","author":"Wu","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"40182","DOI":"10.1038\/srep40182","article-title":"A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/1751-7915.13594","article-title":"The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity","volume":"14","author":"Yuan","year":"2021","journal-title":"Microb. Biotechnol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"29344","DOI":"10.1038\/srep29344","article-title":"LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation","volume":"6","author":"Zhang","year":"2016","journal-title":"SC Rep."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.748718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:23:21Z","timestamp":1634149401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.748718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":40,"alternative-id":["10.3389\/fmicb.2021.748718"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.748718","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"article-number":"748718"}}